Jeremy Chataway
Overview
Explore the profile of Jeremy Chataway including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
157
Citations
2361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doshi A, Muhlert N, Castellazzi G, Alahmadi A, De Angelis F, Prados F, et al.
Mult Scler Relat Disord
. 2025 Feb;
95:106270.
PMID: 39921989
Background: Altered brain network function is associated with cognitive impairment in multiple sclerosis (MS), but recent studies highlight a lack of consensus in the field. These differences may relate to...
2.
De Angelis F, Ammoscato F, Parker R, Plantone D, Doshi A, John N, et al.
Mult Scler
. 2025 Jan;
:13524585241311212.
PMID: 39844621
Background: Biomarkers are needed to track progression in MS trials. Neurofilament heavy chain (NfH) has been underutilized due to assay limitations. Objective: To investigate the added value of cerebrospinal fluid...
3.
De Angelis F, Cameron J, Eshaghi A, Parker R, Connick P, Stutters J, et al.
J Neurol Neurosurg Psychiatry
. 2024 Dec;
PMID: 39694820
Background: Optical coherence tomography (OCT) inner retinal metrics reflect neurodegeneration in multiple sclerosis (MS). We explored OCT measures as biomarkers of disease severity in secondary progressive MS (SPMS). Methods: We...
4.
John N, Li Y, De Angelis F, Stutters J, Prados F, Doshi A, et al.
Eur J Neurol
. 2024 Dec;
32(1):e16586.
PMID: 39691073
Background: Comorbidities including vascular risk factors can be associated with whole and regional brain atrophy in multiple sclerosis (MS). This has been examined in mixed MS cohorts in prospective or...
5.
Motl R, Sandroff B, Hernandez R, Amato M, Brichetto G, Chataway J, et al.
Mult Scler J Exp Transl Clin
. 2024 Dec;
10(4):20552173241301030.
PMID: 39651332
Background: There is heterogeneity of aerobic fitness (VO) changes with a standardized exercise training stimulus in the general population (i.e. some participants demonstrate improvements, others no change, and some a...
6.
Gagliardi D, Wade C, Tucci A, Houlden H, Chataway J, Barkhof F, et al.
J Neurol Neurosurg Psychiatry
. 2024 Dec;
PMID: 39643430
Background: Alexander disease is an autosomal dominant leukodystrophy caused by heterozygous pathogenic variants in the glial fibrillar acidic protein (GFAP) gene. Although increasingly recognised, there is evidence that Alexander disease,...
7.
Arun T, Petheram K, Tallantyre E, Ford H, Chataway J, Dougall N, et al.
Mult Scler Relat Disord
. 2024 Nov;
92:106144.
PMID: 39579643
Therapeutics of neuroinflammatory disorders including multiple sclerosis is one of the fastest growing areas in neurology. However, pressures on higher specialty training in neurology together with an expanding curriculum have...
8.
Palladino R, Chataway J, Mathew M, Majeed A, Marrie R
Mult Scler
. 2024 Oct;
30(13):1653-1663.
PMID: 39420581
Background: People with multiple sclerosis (PwMS) have an increased cardiovascular and cerebrovascular disease burden, but this could be mitigated by vascular risk factor management. Objectives: We compared the trajectories of...
9.
Williams T, John N, Calvi A, Bianchi A, De Angelis F, Doshi A, et al.
Neuroimage Rep
. 2024 Sep;
4(3):100216.
PMID: 39328985
Background: Deep grey matter pathology is a key driver of disability worsening in people with multiple sclerosis. Quantitative susceptibility mapping (QSM) is an advanced magnetic resonance imaging (MRI) technique which...
10.
Williams T, John N, Doshi A, Chataway J
Handb Clin Neurol
. 2024 Sep;
204:399-430.
PMID: 39322392
Inflammatory white matter disorders may commonly mimic genetic leukoencephalopathies. These include atypical presentations of common conditions, such as multiple sclerosis, together with rare inflammatory disorders. A structured approach to such...